Pharmaceutical company guided by ethical principles
Founded in 1983 and based in Milan, Guna S.p.a. is the leading Italian Company in the production and distribution of complementary, low-dose and biological medicine, with a domestic market share of 25% and a turnover of over 61 million Euro in 2017.
The Company’s success is due to the production of innovative, top-quality low-dose medicines, designed and developed in Guna laboratories. Guna produces its own range of cutting-edge and sophisticatedly designed food supplements, medical devices, Bach Flowers and cosmetics. It is also the exclusive Italian distributor for a wide range of medicines and food supplements of prestigious European Companies.
Guna products are distributed in over 30 Countries in the world. Over 70 products are FDA listed and regulated and sold in the US through the subsidiary Guna Inc., located in Pennsylvania.
Every year, Guna invests considerable resources in clinical and basic research studies conducted according to state-of-the-art scientific standards.
Guna has around 300 employees, working in the departments of production, logistics, financial, marketing and medical-scientific information.
In addition to the activity of production and marketing, Guna organizes an intensive program of cultural updating for doctors in many Italian cities and all over the world, aimed at the diffusion of low-dose medicine, with over 600 days of professional training every year. Guna also supports several Associations operating to provide training for physicians and pharmacists.
As a Company, Guna is aware that profit is the ultimate goal and we acknowledge this without any hypocritical attempt to argue otherwise, however we are equally convinced that the search for gain cannot and should not be separate from ethics and meta-social objectives, and that business can have a human face.
Guna invests in scientific research, employment, technological innovation, wellbeing of the people and the environment. More information about our activity in the field of social responsibility are provided in Guna yearly integrated balance sheet (Italian language).